Neurodegenerative Disease Modeling in Caenorhabditis elegans

Caenorhabditis elegans has emerged as a powerful in vivo platform for dissecting the cellular and molecular underpinnings of neurodegenerative disorders. Its transparent body, fully mapped nervous system and conserved pathways allow longitudinal observation of neuronal integrity, protein aggregation and behavioural outcomes over a compressed lifespan. Transgenic lines expressing human disease‐associated proteins such as α-synuclein, tau and TDP-43 recapitulate hallmark features of Parkinson’s, Alzheimer’s and amyotrophic lateral sclerosis, respectively. Chemical and genetic perturbations can be combined to probe environmental contributors, mitochondrial dysfunction and proteostasis failure, while high-throughput screening of small molecules and RNA interference libraries accelerates target validation. Behavioural assays—ranging from locomotion and chemotaxis to food-sensing and defecation rhythm—serve as quantitative proxies for neuronal health. Together, these strengths make C. elegans an accessible yet rigorous model to illuminate early pathogenic events, identify genetic modifiers and evaluate candidate therapeutics, with global relevance to age‐related neurodegeneration in humans.

Research from Nature Portfolio

Recent studies have delineated the role of leucine‐rich repeat kinase 2 in modulating intercellular propagation of α-synuclein. Work in nematode, cell culture and rodent systems shows that pathogenic LRRK2 variants enhance aggregate spread via phosphorylation of the small GTPase RAB35, pointing to kinase inhibition as a strategy to limit protein seeding across synapses. Another body of work has illuminated the mitochondrial unfolded protein response as an intrinsic neuroprotective mechanism. In worms bearing mutations in Parkinson’s‐linked genes PINK1 and PRKN, accumulated dysfunctional mitochondria trigger a stress response that sustains dopaminergic neuron survival and delays behavioural decline, suggesting that boosting this pathway could mitigate neurodegeneration in ageing brains.

Neurodegenerative Disease Modeling in Caenorhabditis elegans publication trend

The graph below shows the total number of articles in neurodegenerative disease modeling in caenorhabditis elegans across all publications each year (not limited to Nature Index journals).

Technical terms

α-synuclein: A neuronal protein prone to misfolding and aggregation, characteristic of Parkinson’s disease pathology.

Dopaminergic neuron: A nerve cell synthesising and releasing dopamine, critical for motor control and affected in Parkinson’s disease.

Mitochondrial unfolded protein response (mitoUPR): A protective signalling cascade activated by accumulation of misfolded proteins within mitochondria.

Proteostasis: The cellular network of pathways that maintain protein folding, trafficking and degradation to preserve functional proteomes.

RNA interference (RNAi): An endogenous mechanism by which double-stranded RNA triggers sequence-specific degradation of complementary messenger RNA, used experimentally for gene silencing.

References

1. Caenorhabditis elegans RAC1/ced-10 mutants as a new animal model to study very early stages of Parkinson’s disease. Progress in Neurobiology (2024).
2. Healthspan Maintenance and Prevention of Parkinson’s-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in C. elegans. International Journal of Molecular Sciences (2020).
3. LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation. Nature Communications (2018).
4. Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson’s disease models. Scientific Reports (2017).
5. Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson’s Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line. International Journal of Molecular Sciences (2020).